Influence of antilymphocyte globulin upon the incidence of malignancies after kidney transplantation.
Luciani
J
J
Département d'Anesthésie-Réanimation, Hôpital Pitie-Salpetriere, Paris, France.
Benalia
H
H
Bitker
M O
MO
Mouquet
C
C
Chartier-Kastler
E
E
Ourhama
S
S
Jacobs
C
C
Chatelain
C
C
Viars
P
P
D000328:Adult; D000367:Age Factors; D000961:Antilymphocyte Serum / Q000009:adverse effects*; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000009:adverse effects; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D008223:Lymphoma / Q000453:epidemiology* / Q000209:etiology; D008875:Middle Aged; D012189:Retrospective Studies; D013997:Time Factors
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine